HOT NEWS
Boehringer Ingelheim
Boehringer IngelheimThe Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and almost 38,900 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2007, Boehringer Ingelheim posted net sales of 10.9 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development. For more information please visit www.boehringer-ingelheim.com.

Boehringer Ingelheim RSS Channel

Title Filter     Display # 
# Article Title Hits
1 A new era for patients with atrial fibrillation - Dabigatran etexilate at the forefront 385
2 Turnover and profit expectations fulfilled for first half-year results 1008
3 Positive Opinion for TWYNSTA®, Boehringer Ingelheim's new single pill combination hypertension treatment 1152
4 Fekrije Selimi wins Boehringer Ingelheim's FENS Award 2010 for Exceptional Research in Neuroscience 1109
5 Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients 1007
6 Boehringer Ingelheim launches Global Venture Fund to foster innovation in life sciences 1121
7 Boehringer Ingelheim and Priaxon announce a collaboration to research and develop novel treatments for cancer 1311
8 Boehringer Ingelheim initiates first Phase III clinical trial in Ovarian Cancer 1858
9 Milestone results in RE-COVER™ study - novel oral direct thrombin inhibitor dabigatran etexilate 1802
10 Major European regulatory milestone in cardiovascular protection for Micardis® (telmisartan) 1362
11 Boehringer Ingelheim and GlaxoSmithKline back EFA's call for urgent improvements in care for people with lung disease 1048
12 Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products 867
13 Boehringer Ingelheim Animal Health closes deal to acquire Animal Health Business from Pfizer 1017
14 Boehringer Ingelheim receives approval from the European Commission for Mirapexin®/Sifrol 1643
15 Access to HIV medication 682
16 Boehringer Ingelheim's diabetes pipeline continues to advance 1694
17 Boehringer Ingelheim Animal Health enters into agreement to acquire certain assets of Fort Dodge Animal Health from Pfizer 1155
18 ERS COPD Research Award 2009 sponsored by Boehringer Ingelheim 1034
19 Novel oral direct thrombin inhibitor dabigatran etexilate convincingly beats warfarin 4017
20 Good first six months in 2009 for Boehringer Ingelheim 826
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share